Information:
Error:
ID
39681
Description
A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01672983
Link
https://clinicaltrials.gov/show/NCT01672983
Keywords
Versions (1)
- 2/9/20 2/9/20 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
February 9, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C Virus NCT01672983
Eligibility Hepatitis C Virus NCT01672983
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Virus NCT01672983
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Peginterferon alfa-2a plus Ribavirin
Item
previously received pegylated interferon alpha-2a/ribavirin.
boolean
C0391001 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C0035525 (UMLS CUI [1,3])
C0332287 (UMLS CUI [1,2])
C0035525 (UMLS CUI [1,3])
Hepatitis C, Chronic
Item
chronic hepatitis c virus infection.
boolean
C0524910 (UMLS CUI [1])
Hepatitis C virus RNA assay Plasma
Item
plasma hepatitis c virus ribonucleic acid level greater than 10,000 international units/milliliter.
boolean
C1272251 (UMLS CUI [1,1])
C0032105 (UMLS CUI [1,2])
C0032105 (UMLS CUI [1,2])
Informed Consent
Item
voluntarily sign an informed consent.
boolean
C0021430 (UMLS CUI [1])
Drug Allergy Severe Life Threatening
Item
history of severe, life-threatening sensitivity to any drug.
boolean
C0013182 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C2826244 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,2])
C2826244 (UMLS CUI [1,3])
Pregnancy | Pregnancy, Planned | Breast Feeding
Item
females who are pregnant or plan to become pregnant, or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Substance Use Disorders
Item
recent history of drug or alcohol abuse.
boolean
C0038586 (UMLS CUI [1])
Hepatitis B surface antigen positive | HIV antibody positive
Item
positive test result for hepatitis b surface antigen or anti-human immunodeficiency virus antibodies.
boolean
C0149709 (UMLS CUI [1])
C0920548 (UMLS CUI [2])
C0920548 (UMLS CUI [2])
Liver Cirrhosis
Item
any current or past clinical evidence of cirrhosis.
boolean
C0023890 (UMLS CUI [1])
Anti-hepatitis C (HCV) Agents | Exception Peginterferon alfa-2a | Exception Ribavirin | ABT-450 | ABT-267
Item
previous use of any investigational or commercially available anti-hepatitis c virus agent other than pegylated interferon alpha-2a and ribavirin, including previous exposure to abt-450 or abt-267.
boolean
C4324240 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0391001 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0035525 (UMLS CUI [3,2])
C3712108 (UMLS CUI [4])
C3713322 (UMLS CUI [5])
C1705847 (UMLS CUI [2,1])
C0391001 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0035525 (UMLS CUI [3,2])
C3712108 (UMLS CUI [4])
C3713322 (UMLS CUI [5])